Dr. Cooperman is an Associate Professor in the Division of Addiction Psychiatry at the Rutgers Robert Wood Johnson Medical School, on the Executive Board as Chair of Treatment and Recovery at the Rutgers Addiction Research Center, and a clinical psychologist specializing in research on substance use disorders. She has been active in developing and evaluating novel behavioral interventions among individuals with substance use disorders for over 20 years. Currently, she is the Principal Investigator of three NIDA HEAL R01 grants to conduct clinical trials to investigate Mindfulness Oriented Recovery Enhancement (MORE) for chronic pain, opioid use, nicotine use, and other drug use in drug treatment programs and primary care. She leads a New Jersey Department of Mental Health and Addiction Services (NJ DMHAS) funded program to provide naloxone to communities and to deliver naloxone administration trainings to prevent opioid overdose, and a NJ Department of Labor (DOL) grant to support the Pathways to Recovery Program, a program to link people in recovery for an opioid use disorder to employment. Previously, she was the Principal Investigator of a NCCIH/NIDA HEAL R21/R33 to evaluate MORE in methadone maintenance treatment, an Arnold Ventures grant to evaluate emergency department peer recovery support for opioid overdose survivors, and a NIDA Career Development Award (K23) study to develop and evaluate a novel smoking cessation intervention for opiate dependent smokers in methadone treatment.